Clinical Trial Detail

NCT ID NCT03244384
Title Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

invasive bladder transitional cell carcinoma

Therapies

Pembrolizumab

Age Groups: senior adult

No variant requirements are available.